CHIEF EDITOR
Brian Kent has participated in advisory boards and/or received speaker fees from Astra Zeneca, Chiesi, GSK, Novartis, and Teva; has received educational travel bursaries from Boehringer Ingelheim, Chiesi, and Napp; and has received research funding from Itamar Medical.
DEPUTY CHIEF EDITOR
Jayesh Mahendra Bhatt is a PI on studies sponsored by AstraZeneca and Boehringer Ingelheim; he has no personal (financial) interests in any pharmaceutical companies.
EDITORIAL BOARD
ERS Education Council, ERS Assembly Secretaries
Frits M.E. Franssen has received grants (to his institution) from AstraZeneca, consulting fees from AstraZeneca, Chiesi and GSK, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, Boehringer Ingelheim, Chiesi and Novartis.
João Carlos Winck has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Armstrong Medical, Philips, Breas and Nippon Gases; and support for attending meetings and/or travel from Vitalaire.
Niki Reynaert has received consortia grants for research from the Dutch Lung Foundation and has patents planned, issued or pending (Detection of glutathionylated proteins, U.S. Pat. Apl. Ser. No.: 11/698,300; Treatments Involving Glutaredoxins and Similar Agents, U.S. Pat. Apl. Ser. No.: 60/934,129; Detection of nitrosylated proteins, US publication number 2005-02874, International publication number WO2005/101019).
Sophia E. Schiza has no potential conflicts of interest to disclose.
Apostolos Bossios has received personal fees (advisory fees and/or lecture honorarium) from Novartis, AstraZeneca, Sanofi, GSK, and TEVA.
Ane Johannessen has no potential conflicts of interest to disclose.
Alexander Möller has received personal fees from Vertex (consultancy fees) and Vifor (lecture fees).
Jellien Makonga-Braaksma has no potential conflicts of interest to disclose.
Raquel Duarte has no potential conflicts of interest to disclose.
Najib M. Rahman has received consultancy fees from Rocket Medical UK, BD Medical USA, Cook Medical and LTI USA.
Michael Kreuter reports grants and fees, to him or his institution, from Roche and Boehringer; personal fees from AstraZeneca, GlaxoSmithKlne, Galapagos and Chiesi.
Olivier Sitbon has received grants or contracts (payment made to his institution) from Janssen (formerly Actelion), Bayer, MSD and GSK; consulting fees from Janssen (formerly Actelion), MSD, Acceleron, Gossamer Bio and Bayer; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Janssen (formerly Actelion), Bayer, MSD, Ferrer, AOP Orphan and GSK; support for attending meetings and/or travel from Janssen (formerly Actelion) and Bayer; payment for participation on a Data Safety Monitoring Board or Advisory Board from Janssen (formerly Actelion), Gossamer Bio, MSD and Acceleron; and medical writing support from Janssen (formerly Actelion).
Pierantonio Laveneziana has received personal fees from Novartis France and from Boehringer France.
Kjeld Hansen has received personal fees from GlaxoSmithKline (speaker reimbursement, Boehringer Ingelheim (consultancy fee), and AstraZeneca (consultancy fee)
Section Editors
Pierantonio Laveneziana has received personal fees from Novartis France and from Boehringer France.
Alexander G. Mathioudakis has received grants from Boehringer Ingelheim,
Associate Editors
Marco Clari has no potential conflicts of interest to disclose.
Gráinne d’Ancona has received fees for teaching or advisory board participation from AstraZeneca and Sanofi; funding to attend conferences from AstraZeneca and Sanofi; and Medical Education Goods and Services (MEGS) grants from AstraZeneca, Chiesi and GSK.
Stefano Elia has no potential conflicts of interest to disclose.
Georgios Kaltsakas has no potential conflicts of interest to disclose.
Julie M. Marchant receives royalty payments from Up-to-Date.
Cormac McCarthy has received grants and speaker fees from Boehringer Ingelheim, and speaker fees from Roche Ltd. He is on the scientific advisory boards of the LAM Foundation and the European Pulmonary Fibrosis Federation. He has a consulting contract with Savara Pharmaceuticals as part of their clinical advisory board.
Paola Pierucci has no potential conflicts of interest to disclose.
Silke Ryan has no potential conflicts of interest to disclose.
Imran Sulaiman has no potential conflicts of interest to disclose.
This page was updated on 10 January 2022